X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (346) 346
index medicus (319) 319
male (211) 211
immunoblastic lymphadenopathy - drug therapy (199) 199
female (181) 181
middle aged (180) 180
aged (154) 154
immunoblastic lymphadenopathy - pathology (131) 131
immunoblastic lymphadenopathy - complications (97) 97
adult (91) 91
lymph nodes - pathology (80) 80
antineoplastic combined chemotherapy protocols - therapeutic use (75) 75
hematology (73) 73
immunoblastic lymphadenopathy - diagnosis (69) 69
lymphoma, t-cell - drug therapy (69) 69
oncology (57) 57
abridged index medicus (53) 53
prednisone - therapeutic use (48) 48
diagnosis, differential (47) 47
lymphadenopathy (42) 42
prognosis (39) 39
lymphoma, t-cell - pathology (38) 38
immunoblastic lymphadenopathy (37) 37
immunoblastic lymphadenopathy - immunology (37) 37
treatment outcome (36) 36
remission induction (35) 35
cyclophosphamide - administration & dosage (34) 34
lymphomas (33) 33
cyclophosphamide - therapeutic use (31) 31
antineoplastic agents - therapeutic use (30) 30
dysproteinemia (30) 30
vincristine - administration & dosage (30) 30
angioimmunoblastic t-cell lymphoma (29) 29
doxorubicin - administration & dosage (29) 29
lymphoma (29) 29
t cells (29) 29
vincristine - therapeutic use (29) 29
angio-immunoblastic lymphadenopathy (27) 27
lymphoma, t-cell - diagnosis (27) 27
non-hodgkins-lymphoma (27) 27
immunoblastic lymphadenopathy - therapy (26) 26
pathology (26) 26
chemotherapy (25) 25
prednisone - administration & dosage (25) 25
aged, 80 and over (24) 24
aids/hiv (24) 24
angioimmunoblastic lymphadenopathy (24) 24
immunoblastic lymphadenopathy - etiology (23) 23
lymphoma, t-cell - complications (23) 23
biopsy (22) 22
doxorubicin - therapeutic use (22) 22
drug therapy, combination (22) 22
epstein-barr-virus (22) 22
t-cell lymphoma (22) 22
non-hodgkin's lymphomas (21) 21
medicine, general & internal (20) 20
fatal outcome (19) 19
antineoplastic combined chemotherapy protocols - administration & dosage (18) 18
expression (18) 18
adolescent (17) 17
immunophenotyping (17) 17
immunosuppressive agents - therapeutic use (17) 17
lymphoma, t-cell, peripheral - drug therapy (17) 17
transplantation (17) 17
child (16) 16
disease (16) 16
epstein-barr virus (16) 16
etoposide - administration & dosage (16) 16
medicine & public health (16) 16
cancer (15) 15
diagnosis (15) 15
lymphoma - pathology (15) 15
skin - pathology (15) 15
immunoblastic lymphadenopathy - genetics (14) 14
immunoblastic lymphadenopathy - mortality (14) 14
prednisolone - therapeutic use (14) 14
therapy (14) 14
time factors (14) 14
animals (13) 13
cyclosporine - therapeutic use (13) 13
features (13) 13
immunoblastic lymphadenopathy - chemically induced (13) 13
lymphoma, large-cell, immunoblastic - drug therapy (13) 13
lymphoproliferative disorders (13) 13
retrospective studies (13) 13
skin neoplasms - pathology (13) 13
antineoplastic agents - administration & dosage (12) 12
antineoplastic combined chemotherapy protocols (12) 12
bone marrow - pathology (12) 12
classification (12) 12
combined modality therapy (12) 12
lymphoma, large-cell, immunoblastic - pathology (12) 12
lymphoma, t-cell - immunology (12) 12
lymphoma, t-cell - mortality (12) 12
neoplasm staging (12) 12
prednisolone - administration & dosage (12) 12
rituximab (12) 12
adrenal cortex hormones - therapeutic use (11) 11
disease-free survival (11) 11
follow-up studies (11) 11
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (292) 292
Japanese (20) 20
French (12) 12
German (10) 10
Chinese (8) 8
Italian (6) 6
Spanish (5) 5
Polish (3) 3
Danish (1) 1
Dutch (1) 1
Hebrew (1) 1
Hungarian (1) 1
Portuguese (1) 1
Russian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 01/2008, Volume 26, Issue 2, pp. 218 - 224
Journal Article
Haematologica, ISSN 0390-6078, 10/2012, Volume 97, Issue 10, pp. 1594 - 1602
Background In angioimmunoblastic T-cell lymphoma, symptoms linked to B-lymphocyte activation are common, and variable numbers of CD20(+) large B-blasts, often... 
Angioimmunoblastic t-cell lymphoma | Epstein-barr virus | Chop-r | VIRAL LOAD | MULTICENTER | angioimmunoblastic T-cell lymphoma | FOLLICULAR HELPER-CELL | NON-HODGKINS-LYMPHOMAS | PERIPHERAL-BLOOD | REARRANGEMENTS | PREDNISONE | POLYMERASE-CHAIN-REACTION | Epstein-Barr virus | CHOP-R | HEMATOLOGY | EXPRESSION | EPSTEIN-BARR-VIRUS | Doxorubicin - therapeutic use | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Immunoblastic Lymphadenopathy - mortality | B-Lymphocytes - virology | Female | Immunoblastic Lymphadenopathy - pathology | B-Lymphocytes - pathology | Prednisone - adverse effects | Rituximab | Immunoblastic Lymphadenopathy - drug therapy | Treatment Outcome | B-Lymphocytes - drug effects | Lymphoma, T-Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, T-Cell - pathology | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Lymphoma, T-Cell - mortality | Antibodies, Monoclonal, Murine-Derived - pharmacology | Neoplasm Staging | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Index Medicus | Original and Brief Reports
Journal Article
Cell Cycle, ISSN 1538-4101, 06/2016, Volume 15, Issue 12, pp. 1545 - 1551
Journal Article
Journal Article
Internal Medicine, ISSN 0918-2918, 2016, Volume 55, Issue 6, pp. 673 - 675
Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive T-cell lymphoma. A 63-year-old man was diagnosed with AITL. He received 6 cycles of CHOP therapy,... 
mogamulizumab | cytomegalovirus pneumonia | lymphoma | Cytomegalovirus pneumonia | Lymphoma | Mogamulizumab | LEUKEMIA-LYMPHOMA | MEDICINE, GENERAL & INTERNAL | MULTICENTER PHASE-II | INFECTION | KW-0761 | EXPRESSION | CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Lymphoma, T-Cell - immunology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Pneumonia, Viral - drug therapy | Pneumonia, Viral - etiology | Drug Resistance, Neoplasm | Immunoblastic Lymphadenopathy - physiopathology | Male | Cytomegalovirus Infections - immunology | Cisplatin - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacology | Fatal Outcome | Cytomegalovirus Infections - etiology | Vincristine - administration & dosage | Lymphoma, T-Cell - physiopathology | Doxorubicin - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Prednisone - administration & dosage | Etoposide - administration & dosage | Immunoblastic Lymphadenopathy - drug therapy | Antiviral Agents - administration & dosage | Pneumonia, Viral - immunology | Cytarabine - administration & dosage | Disease Progression | Receptors, CCR4 - antagonists & inhibitors | Lymphoma, T-Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cytomegalovirus Infections - drug therapy | Immunoblastic Lymphadenopathy - immunology | Anti-Bacterial Agents - administration & dosage | Pneumonia, Viral - virology | Methylprednisolone - administration & dosage | Index Medicus
Journal Article
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 09/2015, Volume 56, Issue 9, pp. 2592 - 2597
Journal Article
Journal Article
Heart Surgery Forum, ISSN 1098-3511, 2017, Volume 20, Issue 2, pp. E43 - E44
Journal Article
International Journal of Hematology, ISSN 0925-5710, 9/2013, Volume 98, Issue 3, pp. 366 - 374
Journal Article
American Journal of Hematology, ISSN 0361-8609, 09/2012, Volume 87, Issue 9, pp. 927 - 928
Journal Article
Haematologica, ISSN 0390-6078, 11/2003, Volume 88, Issue 11, pp. 1272 - 1278
Journal Article